Centro Español de Investigación Farmacoepidemiológica

Recent papers from Centro Español de Investigación Farmacoepidemiológica

1. Risk of recurrent ischemic stroke after non-cardioembolic ischemic stroke in England and DenmarkJournal of Neurology · 2026
2. Abstract Number: Esoc2026a381 Functional Impairment Patterns Following Recurrent Ischaemic Stroke in Patients With a History of Non-Cardioembolic Stroke: An Observational StudyEuropean Stroke Journal · 2026
3. Abstract Number: Esoc2026a2264 Recurrent Ischemic Stroke and Major Bleeding After Ischemic Stroke in Patients With Atrial Fibrillation on Oral Anticoagulants: A Nationwide Cohort StudyEuropean Stroke Journal · 2026
4. Incidence of multiple sclerosis in UK general practice; Risk of infections and mortalityMultiple Sclerosis and Related Disorders · 2026
5. Population-based epidemiological analysis of acute pyelonephritis and antibiotic prescription in Spain (2009–2018)PLoS ONE · 2025
6. Prior Dual Antiplatelet Therapy and Mortality After Intracerebral Hemorrhage: A Danish Nationwide Cohort StudyJournal of the American Heart Association · 2025
7. Proton Pump Inhibitor Use and Worsening Kidney Function: A Retrospective Cohort Study Including 122,606 Acid-Suppressing UsersJournal of General Internal Medicine · 2024
8. Association of Prior Antithrombotic Drug Use with 90-Day Mortality After Intracerebral HemorrhageClinical Epidemiology · 2024
9. Relationship between academic climate and burnout in Spanish medical schoolsEducación Médica · 2024
10. Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral AnticoagulantsJAMA Neurology · 2024
11. Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countriesPLoS ONE · 2024
12. Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in EuropeBMJ Open · 2024
13. Safety profile of rivaroxaban in first-time users treated for venous thromboembolism (deep vein thrombosis and pulmonary embolism) in four European countries2023
14. Major Cardiovascular Events After Spontaneous Intracerebral Hemorrhage by Hematoma LocationJAMA Network Open · 2023
15. Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countriesExpert Opinion on Drug Safety · 2023
16. Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UKBMJ Open Diabetes Research & Care · 2023
17. Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United KingdomClinical Epidemiology · 2022
18. Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular EventsJAMA Network Open · 2022
19. Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysisJournal of Medical Economics · 2022
20. Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic strokePharmacoepidemiology and Drug Safety · 2022